Sources

11 Total Sources

Takeda's Zasocitinib Beats Sotyktu With 35% Skin Clearance in Psoriasis Trial

Center100%

BioPharma Dive1d ago

Takeda's Zasocitinib Outperforms Bristol Myers Squibb's Sotyktu in Psoriasis Trial

Takeda's AI-crafted psoriasis pill tops Bristol Myers' Sotyktu in head-to-head trial | Reuters

BioSpace12h ago

Takeda's AI-designed pill bests BMS' Sotyktu in head-to-head psoriasis trial - BioSpace

Takeda's psoriasis pill beats Sotyktu. The question is whether anyone cares.

intellectia.ai1d ago

Takeda's Zasocitinib Outperforms Rival in Psoriasis Trial | Intellectia.AI

Takeda's TYK2 inhibitor beats Bristol Myers' Sotyktu in phase 3 psoriasis showdown : r/biotech

The Pharma Letter10h ago

Takeda's zasocitinib outperforms deucravacitinib in PsO | The Pharmaletter

pharmaphorum1d ago

Takeda's TYK2 drug bests BMS's Sotyktu in psoriasis contest | pharmaphorum

GuruFocus.com1d ago

Takeda (TAK) Shows Strong Efficacy of Zasocitinib in Psoriasis T

dermatologytimes.com1d ago

Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show | Dermatology Times

MD Magazine1d ago

Zasocitinib Bests Deucravacitinib on PsO Skin Clearance in Phase 3 Head-to-Head | HCPLive